NANOHYBRID CO., LTD.
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 28, 2015 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 10 Total Citation Count
- Jul 26, 2002 Earliest Filing
- 8 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0220,647 NANO-HYBRID OF TARGETABLE SIRNA-LAYERED INORGANIC HYDROXIDE, MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR TREATING TUMOR COMPRISING THE NANO-HYBRIDAbandonedSep 14, 09Aug 30, 12[A61K, A61P]
8030506 Tumor selective and biodegradable cyclotriphosphazene-platinum(II) conjugate anticancer agent, and preparation method thereofExpiredApr 11, 08Oct 04, 11[A61K, C07F]
2010/0047,307 INJECTABLE DRUG CARRIER COMPRISING LAYERED DOUBLE HYDROXIDEAbandonedJun 03, 05Feb 25, 10[A61K, A61P]
2008/0153,907 Pharmaceutical Composition for the Treatment of Cancer Comprising Lhm-Ra ComplexAbandonedFeb 22, 06Jun 26, 08[A61K, A61P]
2008/0119,519 Base Forming Drug-Layered Silicate Hybrid Containing Basic Polymer and its Synthesis MethodAbandonedFeb 21, 06May 22, 08[A61K]
2007/0220,713 Method for Forming Zno Nano-Array and Zno Nanowall for Uv Laser On Silicon SubstrateAbandonedNov 06, 04Sep 27, 07[B82B]
2006/0084,171 Thermosensitive and biocompatible amphiphilic cyclic phosphazene trimer and preparation method thereofAbandonedOct 14, 05Apr 20, 06[C08G]
2006/0013,877 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the sameAbandonedJul 22, 03Jan 19, 06[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.